{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:22:59Z","timestamp":1791141779981,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-40610"],"award-info":[{"award-number":["2020-4-40610"]}]},{"name":"The China-Japan Friendship Hospital project","award":["2021-HX-57"],"award-info":[{"award-number":["2021-HX-57"]}]},{"name":"Elite Medical Professionals project of China-Japan Friendship Hospital","award":["ZRJY2021-QM14"],"award-info":[{"award-number":["ZRJY2021-QM14"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-NHLHCRF-LX-02"],"award-info":[{"award-number":["2022-NHLHCRF-LX-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Currently, only a few studies have described the general characteristics of patients with primary Sj\u00f6gren\u2019s syndrome (pSS) who tested negatives for anti-SSA and anti-SSB antibodies. We aimed to further investigate the clinical characteristics of these patients in a large sample.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from patients with pSS who were treated at a tertiary hospital in China between 2013 and 2022 were retrospectively analyzed. Clinical characteristics of the patients were compared between those with and without anti-SSA and anti-SSB antibody negativity. Factors associated with anti-SSA and anti-SSB negativity were identified by logistic regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 934 patients with pSS were included in this study, among whom 299 (32.0%) tested negative for anti-SSA and anti-SSB antibodies. Compared with patients testing positive for anti-SSA or anti-SSB antibodies, that testing negative for the two antibodies had a lower proportion of females (75.3% vs. 90.6%, p\u2009&lt;\u20090.001) and thrombocytopenia (6.7% vs. 13.6%, p\u2009=\u20090.002), but a higher proportion of abnormal Schirmer I tests (96.0% vs. 89.1%, p\u2009=\u20090.001) and interstitial lung disease (ILD) (59.2% vs. 28.8%, p\u2009=\u20090.001). Anti-SSA and anti-SSB negativity was positively associated with male sex (odds ratio [OR]\u2009=\u20091.86, 95% confidence interval [CI]: 1.05, 3.31), abnormal Schirmer I tests (OR\u2009=\u20092.85, 95% CI: 1.24, 6.53), and ILD (OR\u2009=\u20092.54, 95% CI: 1.67, 3.85). However, it was negatively related to thrombocytopenia (OR\u2009=\u20090.47, 95% CI: 0.24, 0.95).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Approximately one third of pSS patients had anti-SSA and anti-SSB negativity. pSS patients testing negative for anti-SSA and anti-SSB showed a higher risk of abnormal Schirmer I tests and ILD, but a lower risk of thrombocytopenia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42358-023-00304-4","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:31:23Z","timestamp":1684161083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-SSA\/SSB-negative primary Sj\u00f6gren\u2019s syndrome showing different clinical phenotypes: a retrospective study of 934 cases"],"prefix":"10.1186","volume":"63","author":[{"given":"Jiaqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TzuHua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2454-2168","authenticated-orcid":false,"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"304_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA. Primary Sj\u00f6gren\u2019s Syndrome. N Engl J Med. 2018;378:931\u201339.","journal-title":"N Engl J Med"},{"key":"304_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne G, Mariette X. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2018;14:133\u201345.","journal-title":"Nat Rev Rheumatol"},{"key":"304_CR3","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sj\u00f6gren syndrome. Nat Rev Dis Primers. 2016;2:16047.","journal-title":"Nat Rev Dis Primers"},{"key":"304_CR4","doi-asserted-by":"publisher","first-page":"13921","DOI":"10.1038\/s41598-017-14089-2","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu Z, Zeng W, Huang X, Wang S, Zheng J, Pan M, Wang Y. Peripheral CD19hi B cells exhibit activated phenotype and functionality in promoting IgG and IgM production in human autoimmune diseases. Sci Rep. 2017;7:13921.","journal-title":"Sci Rep"},{"key":"304_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7150\/ijms.17718","volume":"14","author":"T Both","year":"2017","unstructured":"Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sj\u00f6gren\u2019s syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment. Int J Med Sci. 2017;14:191\u2013200.","journal-title":"Int J Med Sci"},{"key":"304_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the european criteria proposed by the american-european Consensus Group. Ann Rheum Dis. 2002;61:554\u201358.","journal-title":"Ann Rheum Dis"},{"key":"304_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a Consensus and Data-Driven Methodology Involving Three International Patient cohorts. Arthritis Rheumatol. 2017;69:35\u201345.","journal-title":"Arthritis Rheumatol"},{"key":"304_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012;64:475\u201387.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"304_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.rdc.2016.03.002","volume":"42","author":"A Fayyaz","year":"2016","unstructured":"Fayyaz A, Kurien BT, Scofield RH. Autoantibodies in Sj\u00f6gren\u2019s Syndrome. Rheum Dis Clin North Am. 2016;42:419\u201334.","journal-title":"Rheum Dis Clin North Am"},{"key":"304_CR10","first-page":"354","volume":"114","author":"AL Stefanski","year":"2017","unstructured":"Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, D\u00f6rner T. The diagnosis and treatment of Sj\u00f6gren\u2019s Syndrome. Dtsch Arztebl Int. 2017;114:354\u201361.","journal-title":"Dtsch Arztebl Int"},{"key":"304_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.autrev.2015.07.002","volume":"14","author":"L Quartuccio","year":"2015","unstructured":"Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, et al. Anti-SSA\/SSB-negative Sj\u00f6gren\u2019s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Autoimmun Rev. 2015;14:1019\u201322.","journal-title":"Autoimmun Rev"},{"key":"304_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10067-020-05154-9","volume":"40","author":"V Yazisiz","year":"2021","unstructured":"Yazisiz V, Aslan B, Erbasan F, U\u00e7ar \u0130, \u00d6\u011f\u00fct TS, Terzio\u011flu ME. Clinical and serological characteristics of seronegative primary Sj\u00f6gren\u2019s syndrome: a comparative study. Clin Rheumatol. 2021;40:221\u201329.","journal-title":"Clin Rheumatol"},{"issue":"Suppl 126","key":"304_CR13","first-page":"291","volume":"38","author":"F Luppi","year":"2020","unstructured":"Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, et al. Interstitial lung disease in Sj\u00f6gren\u2019s syndrome: a clinical review. Clin Exp Rheumatol. 2020;38(Suppl 126):291\u2013300.","journal-title":"Clin Exp Rheumatol"},{"key":"304_CR14","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/art.30381","volume":"63","author":"TE Daniels","year":"2011","unstructured":"Daniels TE, Cox D, Shiboski CH, Schi\u00f8dt M, Wu A, Lanfranchi H, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sj\u00f6gren\u2019s syndrome among 1,726 registry participants. Arthritis Rheum. 2011;63:2021\u201330.","journal-title":"Arthritis Rheum"},{"key":"304_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/annrheumdis-2020-218881","volume":"80","author":"N Kajio","year":"2021","unstructured":"Kajio N, Takeshita M, Suzuki K, Kaneda Y, Yamane H, Ikeura K, et al. Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling. Ann Rheum Dis. 2021;80:651\u201359.","journal-title":"Ann Rheum Dis"},{"key":"304_CR16","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/acr.24597","volume":"74","author":"B Arma\u011fan","year":"2022","unstructured":"Arma\u011fan B, Robinson SA, Bazoberry A, Perin J, Grader-Beck T, Akpek EK, et al. Antibodies to both Ro52 and Ro60 for identifying Sj\u00f6gren\u2019s Syndrome Patients best suited for clinical trials of Disease-Modifying Therapies. Arthritis Care Res (Hoboken). 2022;74:1559\u201365.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"304_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","volume":"25","author":"N Nardi","year":"2006","unstructured":"Nardi N, Brito-Zer\u00f3n P, Ramos-Casals M, Aguil\u00f3 S, Cervera R, Ingelmo M, et al. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sj\u00f6gren\u2019s syndrome: prevalence and clinical significance in 335 patients. Clin Rheumatol. 2006;25:341\u201346.","journal-title":"Clin Rheumatol"},{"key":"304_CR18","first-page":"837","volume":"60","author":"GE Thorlacius","year":"2021","unstructured":"Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P, et al. Genetic and clinical basis for two distinct subtypes of primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2021;60:837\u201348.","journal-title":"Rheumatology (Oxford)"},{"key":"304_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5114\/reum.2018.80711","volume":"56","author":"E Kontny","year":"2018","unstructured":"Kontny E, Lewandowska-Poluch A, Chmieli\u0144ska M, Olesi\u0144ska M. Subgroups of Sj\u00f6gren\u2019s syndrome patients categorised by serological profiles: clinical and immunological characteristics. Reumatologia. 2018;56:346\u201353.","journal-title":"Reumatologia"},{"key":"304_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","volume":"40","author":"EJ ter Borg","year":"2011","unstructured":"ter Borg EJ, Risselada AP, Kelder JC. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren\u2019s syndrome: a retrospective analysis of 65 patients in the Netherlands. Semin Arthritis Rheum. 2011;40:547\u201351.","journal-title":"Semin Arthritis Rheum"},{"key":"304_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients. Med (Baltim). 2008;87:210\u201319.","journal-title":"Med (Baltim)"},{"key":"304_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/ard.61.10.929","volume":"61","author":"I Peene","year":"2002","unstructured":"Peene I, Meheus L, De Keyser S, Humbel R, Veys EM, De Keyser F. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis. 2002;61:929\u201333.","journal-title":"Ann Rheum Dis"},{"key":"304_CR23","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/ar2958","volume":"12","author":"VK Bournia","year":"2010","unstructured":"Bournia VK, Diamanti KD, Vlachoyiannopoulos PG, Moutsopoulos HM. Anticentromere antibody positive Sj\u00f6gren\u2019s syndrome: a retrospective descriptive analysis. Arthritis Res Ther. 2010;12:R47.","journal-title":"Arthritis Res Ther"},{"key":"304_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3899\/jrheum.190462","volume":"47","author":"Y Li","year":"2020","unstructured":"Li Y, Bookman AAM. Comparison of Effect on Sicca symptoms of Anticentromere antibody-positive Sj\u00f6gren Syndrome and primary Sj\u00f6gren syndrome alone. J Rheumatol. 2020;47:876\u201380.","journal-title":"J Rheumatol"},{"key":"304_CR25","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/acr.22859","volume":"68","author":"AN Baer","year":"2016","unstructured":"Baer AN, Medrano L, McAdams-DeMarco M, Gniadek TJ. Association of Anticentromere antibodies with more severe exocrine glandular dysfunction in Sj\u00f6gren\u2019s syndrome: analysis of the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance Cohort. Arthritis Care Res (Hoboken). 2016;68:1554\u201359.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"304_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00296-004-0568-4","volume":"26","author":"TC Hsu","year":"2006","unstructured":"Hsu TC, Chang CH, Lin MC, Liu ST, Yen TJ, Tsay GJ. Anti-CENP-H antibodies in patients with Sjogren\u2019s syndrome. Rheumatol Int. 2006;26:298\u2013303.","journal-title":"Rheumatol Int"},{"key":"304_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/acn3.51053","volume":"7","author":"J Tani","year":"2020","unstructured":"Tani J, Liao HT, Hsu HC, Chen LF, Chang TS, Shin-Yi Lin C, et al. Immune-mediated axonal dysfunction in seropositive and seronegative primary Sj\u00f6gren\u2019s syndrome. Ann Clin Transl Neurol. 2020;7:819\u201328.","journal-title":"Ann Clin Transl Neurol"},{"key":"304_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.chest.2020.10.011","volume":"159","author":"AS Lee","year":"2021","unstructured":"Lee AS, Scofield RH, Hammitt KM, Gupta N, Thomas DE, Moua T, et al. Consensus Guidelines for evaluation and management of Pulmonary Disease in Sj\u00f6gren\u2019s. Chest. 2021;159:683\u201398.","journal-title":"Chest"},{"key":"304_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/1756-185X.13881","volume":"23","author":"C He","year":"2020","unstructured":"He C, Chen Z, Liu S, Chen H, Zhang F. Prevalence and risk factors of interstitial lung disease in patients with primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Int J Rheum Dis. 2020;23:1009\u201318.","journal-title":"Int J Rheum Dis"},{"key":"304_CR30","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10067-018-4289-6","volume":"37","author":"X Dong","year":"2018","unstructured":"Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sj\u00f6gren\u2019s syndrome-related interstitial lung disease in a chinese population. Clin Rheumatol. 2018;37:2981\u201388.","journal-title":"Clin Rheumatol"},{"key":"304_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10067-019-04753-5","volume":"39","author":"R Zhao","year":"2020","unstructured":"Zhao R, Wang Y, Zhou W, Guo J, He M, Li P, et al. Associated factors with interstitial lung disease and health-related quality of life in chinese patients with primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 2020;39:483\u201389.","journal-title":"Clin Rheumatol"},{"key":"304_CR32","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1080\/07853890.2021.1965205","volume":"53","author":"T Guo","year":"2021","unstructured":"Guo T, Long Y, Shen Q, Guo W, Duan W, Ouyang X, et al. Clinical profiles of SS-ILD compared with SS-NILD in a chinese population: a retrospective analysis of 735 patients. Ann Med. 2021;53:1340\u201348.","journal-title":"Ann Med"},{"key":"304_CR33","doi-asserted-by":"publisher","first-page":"102447","DOI":"10.1016\/j.autrev.2019.102447","volume":"19","author":"G Sambataro","year":"2020","unstructured":"Sambataro G, Ferro F, Orlandi M, Sambataro D, Torrisi SE, Quartuccio L, et al. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj\u00d3\u00a7gren\u2019s syndrome: a systematic review from the italian society of Rheumatology. Autoimmun Rev. 2020;19:102447.","journal-title":"Autoimmun Rev"},{"key":"304_CR34","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00296-017-3715-4","volume":"37","author":"EJ Ter Borg","year":"2017","unstructured":"Ter Borg EJ, Kelder JC. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sj\u00f6gren\u2019s syndrome: a long-term study of the Antonius Nieuwegein Sj\u00f6gren (ANS) cohort. Rheumatol Int. 2017;37:1153\u201358.","journal-title":"Rheumatol Int"},{"key":"304_CR35","doi-asserted-by":"crossref","unstructured":"Manfredi A, Sebastiani M, Cerri S, Cassone G, Bellini P, Casa GD et al. Prevalence and characterization of non-sicca onset primary Sj\u00f6gren syndrome with interstitial lung involvement published correction appears in Clin Rheumatol. 2017;36:1261\u201368.","DOI":"10.1007\/s10067-017-3601-1"},{"key":"304_CR36","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s10067-020-05017-3","volume":"39","author":"ME Yayla","year":"2020","unstructured":"Yayla ME, Karaman Z, Torgutalp M, Kele\u015fo\u011flu Din\u00e7er AB, Aydemir G\u00fcl\u00f6ks\u00fcz EG, Sezer S, et al. Early onset primary Sj\u00f6gren syndrome, clinical and laboratory characteristics. Clin Rheumatol. 2020;39:2689\u201396.","journal-title":"Clin Rheumatol"},{"key":"304_CR37","doi-asserted-by":"publisher","first-page":"e26777","DOI":"10.1097\/MD.0000000000026777","volume":"100","author":"H Gao","year":"2021","unstructured":"Gao H, Sun Y, Zhang XY, Xie L, Zhang XW, Zhong YC, et al. Characteristics and mortality in primary Sj\u00f6gren syndrome-related interstitial lung disease. Med (Baltim). 2021;100:e26777.","journal-title":"Med (Baltim)"},{"key":"304_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13293-015-0037-7","volume":"6","author":"JE Brandt","year":"2015","unstructured":"Brandt JE, Priori R, Valesini G, Fairweather D. Sex differences in Sj\u00f6gren\u2019s syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ. 2015;6:19.","journal-title":"Biol Sex Differ"},{"key":"304_CR39","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W. Immune Thrombocytopenia. N Engl J Med. 2019;381:945\u201355.","journal-title":"N Engl J Med"},{"issue":"12","key":"304_CR40","first-page":"2245","volume":"40","author":"J Luo","year":"2022","unstructured":"Luo J, Song WJ, Chen JQ, Yang GY, Yang JY, Yu XB, et al. Factors associated with secondary immune thrombocytopenia in patients with primary Sj\u00f6gren\u2019s syndrome: a retrospective study of 639 cases. Clin Exp Rheumatol. 2022;40(12):2245\u201352.","journal-title":"Clin Exp Rheumatol"},{"key":"304_CR41","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.12659\/MSM.895144","volume":"21","author":"YH Hu","year":"2015","unstructured":"Hu YH, Zhou PF, Long GF, Tian X, Guo YF, Pang AM, et al. Elevated plasma P-Selectin autoantibodies in primary Sj\u00f6gren Syndrome patients with Thrombocytopenia. Med Sci Monit. 2015;21:3690\u201395.","journal-title":"Med Sci Monit"},{"key":"304_CR42","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211020179","author":"J Qian","year":"2021","unstructured":"Qian J, He C, Li Y, Peng L, Yang Y, Xu D, et al. Ten-year survival analysis of patients with primary Sj\u00f6gren\u2019s syndrome in China: a national prospective cohort study. Ther Adv Musculoskelet Dis. 2021. https:\/\/doi.org\/10.1177\/1759720X211020179.","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-023-00304-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-023-00304-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-023-00304-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:32:05Z","timestamp":1684161125000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-023-00304-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1186\/s42358-023-00304-4","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of the China-Japan Friendship Hospital (approval number: 2021-144-K102). The need for informed consent was waived, because the datasets were anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent participate"}},{"value":"was waived because this is a retrospective study and the datasets are devoid of personally identifiable information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}